Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Pa
Go back to Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Pa| Arbios Systems, Inc. (NASDAQ: ABOS) | Delayed: 2.36 +0.15 (6.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.21 | 52 Week High | $0.23 | |||
| Open | $2.20 | 52 Week Low | $0.00 | |||
| Day High | $2.38 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $0.00 | |||
| Volume | 5,570,948 | |||||
